Fundación Instituto Valenciano de Oncología-Oncologico ( Site 0202)

Valencia, Valenciana, Comunitat 46009

0 studies enrolling now · 1 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61) — Completed